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ABSTRACT 
Objective: The aim of this study was to prepare fast dissolving tablet of Ramipril by using Sodium starch glycolate, and Crospovidone as 
superdisintegrants to enhance the dissolution rate and the disintegration rate and evaluated for Pre and Post Compression parameter of the tablet.  
Methods: Fast dissolving tablet of Ramipril was prepared by direct compression technique. Fast dissolving tablet was evaluated for Pre 
compression parameter; bulk density, tapped density, Hausner’s ratio, angle of repose and Carr’s index and post compression parameter; weight 
variation, thickness, hardness, friability, wetting time, water absorption ratio, disintegration time and dissolution time. The UV-spectrophotometric 
method has been used for the quantitation of drug release of Ramipril in the Fast dissolving tablet formulation. 
Results: Pre and post compression parameter were evaluated. Five different batches of tablets, F1 to F5 were prepared. Bulk density and tapped 
density was found in the range of 0.64-0.85 g/cm3 and 0.68-0.98 g/cm3
Conclusion: The result suggested that the dissolution and disintegration of Ramipril have improved considerably in batch F4 formulation as 
compared to rest of the formulation. The dissolution rate and dissolution rate of Ramipril can be enhanced to a great extent by the direct 
compression technique with the addition of superdisintegrants. 
 simultaneously. The hardness, friability, wetting time, the water absorption 
ratio, disintegration and dissolution time were found to be acceptable according to the standard limit and compare to all formulations F4 
formulation was selected as the promising formulation. All batches of fast dissolving tablet were satisfactory in term of dissolution. The cumulative 
percentage of drug release of F4 formulation was 90.12% after 12 min compare to other formulation. 
Keywords: Fast dissolving tablet, Ramipril, Sodium starch glycolate, Crospovidone. 
 
INTRODUCTION 
Oral routes of drug administration have wide acceptance up to 50-
60% of total dosage form. Fast dissolving tablets offer great 
advantages for the patients having difficulty in swallowing. It has 
been reported that dysphasia (difficulty in swallowing) is usual 
among all groups and more specific with pediatric, geriatric 
population along with patients have nausea, retching, and motion 
sickness complications [1]. Fast dissolving tablets overcome this 
problem and provide the advantages for pediatrics, geriatric [2-
3],bedridden, disabled patients and also for who may have difficulty 
in swallowing tablets, capsules and liquid orals. FDT will rapidly 
disintegrate in the mouth without the need of water [4-5]. Fast 
dissolving tablet formulation provides sufficient strength, quick 
disintegration/ dissolution in the mouth without water [6], rapid 
dissolution and absorption of the drug, which will produce the quick 
onset of action. Pre gastric absorption of FDT can result in improved 
bioavailability and as a consequence of reduced dose [7]. In addition, 
FDT is applicable when local action is desirable, such as oral ulcers, 
cold sores and teething [8].  
Ramipril is (2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenyl 
butan-2-yl]amino} propanoyl] octahydrocyclopenta [b]pyrrole-2-
carboxylic acid. Ramipril is a 2-aza-bicyclo[3.3.0]-octane-3-
carboxylic acid derivative. Ramiprilat is the active metabolite of 
Ramipril, competes with angiotensin I for binding at the angiotensin 
converting enzyme, blocking the conversion of angiotensin I to 
angiotensin II. Angiotensin II contracts the muscles of most arteries 
in the body, including the heart, thereby narrowing the arteries and 
elevating the blood pressure [9]. Ramipril is indicated for the 
treatment of mild to moderate high blood pressure [10], Congestive 
heart failure, myocardial infarction in patients with clinical evidence 
of heart failure [11]. Ramipril, a pro drug, is converted to the active 
metabolite Ramiprilat by liver esterase enzymes [12]. Even then, it 
may induce hypotension, cough and other side effects [13]. The aim 
of the present study is to represent the formulation development of 
Fast dissolving tablet of Ramipril by using Sodium starch glycolate, 
and Crospovidone as superdisintegrants to enhance the dissolution 
rate and the disintegration rate and evaluated for Pre and Post 
Compression parameter of FDT. 
MATERIALS AND METHODS  
Chemicals and reagents 
Ramipril was a generous gift from Alkam pharmaceutical Ltd. Baddi, 
(India), Sodium starch glycolate, crospovidone, aspartame, lactose, 
microcrystalline cellulose (MCC), Magnesium Stearate, methanol and 
talc was purchased from Himedia Laboratories Pvt. Ltd, Mumbai 
(India). All other chemicals used were of reagent grade. Triple 
distilled water was used throughout the study.  
Preparation of fast dissolving tablet (FDT) of ramipril  
Fast dissolving tablet (FDT) of Ramipril was prepared by direct 
compression method [14]. Five different batches of tablets were 
prepared by direct compression method. The fast dissolving tablets 
were prepared by direct compression of Co-processed 
superdisintegrants likewise Sodium starch glycolate, and 
Crospovidone with Ramipril [15-16]. FDT prepared by using a 
physical mixture of superdisintegrants and Co-processed 
superdisintegrants. In this method drug was mixed with Sodium 
starch glycolate, Crospovidone, Lactose, MCC, aspartame, talc as 
gliding & magnesium stearate as the lubricant. All ingredients were 
passed through #60 mesh, and then the Single punching machine 
was used to compress tablet containing 20 mg of Ramipril at an 
average weight of 250 mg/tablet. Different combination of batches 
was prepared and presented in table 1. Chemical structure, of (a) 
Ramipril and (b) Cross povidone was shown in fig. 1. 
Evaluation of tablets 
Fourier transform infrared spectroscopy  
FTIR spectra were obtained on a Perkin-Elmer 1600 FTIR 
spectrometer (1600 series, Perkin Elmer Inc, Norwalk, CT). Sample 
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was prepared in KBr disk (2 mg sample in 200 mg KBr). 
The scanning range was 400 to 4000 cm−1 and the resolution was 1 c
m−1
 
Fig. 1: Chemical structure of (a) Ramipril and (b) Crospovidone 
. FTIR Spectrum of Ramipril, Crospovidone and combination of 
Ramipril and Crospovidone both were shown in fig. 2. 
 
 
Pre compression parameter 
Physical properties of tablets 
Pre compression parameter of 5 different formulation batches (F1 to 
F5) were evaluated for bulk density, tapped density, Hausner’s ratio, 
angle of repose and Carr’s index. This Define the Physical properties 
of the formulation. 
Bulk density [17] 
Both loose bulk density (LBD) and tapped bulk density (TBD) were 
determined by transferring the accurate weighed amount of sample 
in 50 ml measuring cylinder, the granules without any agglomerates 
and measured the volume of packing and tapped 50 times on a plane 
surface and tapped volume of packing recorded and LBD and TBD 
calculated by following formula. 
LBD =Mass of powder/Volume of packing 
TBD= Mass of powder/Tapped volume of packing. 
 
 
Fig. 2: FT-IR spectra of Ramipril, Crospovidone and combination 
 
Table 1: Different combination of batches (F1-F5) of FDT formulation 
Ingredients (mg)  Formulation code 
F1 F2 F3 F4 F5 
Ramipril 20 20 20 20 20  
Crospovidone 55 55 55 55 55  
Sodium starch glycolate 50 55 60 65 70 
Microcrystalline cellulose 90 90 90 90 90 
Lactose 30 25 20 15 15 
Talc 2.5 2.5 2.5 2.5 2.5 
Mg. Stearate 2.5 2.5 2.5 2.5 2.5 
*n=3, Average of three determinations; F1-F5= formulation code of Fast dissolving tablet; All the quantities expressed are in mg/tablet. 
Formulations F4 was selected as the promising and used for further studies. 
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Hausner’s ratio  
Hausner’s ratio is computed by applying the next equation 
Hausner’s ratio= Tapped density/Bulk density 
Percentage compressibility index [18] 
Percentage compressibility of powder mix was determined by Carr’s 
Compressibility Index calculated by the following formula.  
% Carr’s Index= (TBD-LBD)×100/TBD; Where, TBD= Tapped bulk 
density; LBD= Loose bulk density. 
Angle of repose  
The frictional forces in loose powder or granules can be measured 
by the angle of repose. This is the maximum angle possible between 
the surface of a mass of powder or granules and the horizontal 
plane. Angle of repose is calculated by applying the next equation;  
tan θ = h/r; θ=tan-1
Post compression parameters 
(h/r), where θ=angle of repose; h=height; 
r=radius 
Thickness uniformity[19] 
The aim of the present study was to check the uniformity of 
thickness of the tablet. The thickness of the tablet was measured at 3 
different points using a digital caliper and the average thickness of 
three readings was calculated. 
Hardness test[20] 
Hardness indicates the ability of a tablet to withstand mechanical 
shocks while handling. The hardness of the tablet was determined 
using Monsanto hardness tester and expressed in kg/cm².  
Friability test 
Friability test is performed to assess the effect of friction and 
shocks, which may often cause the tablet to chip, cap or break. 
Roche Friabilator was used for the purpose. Pre weight sample 
of ten tablets was placed in the friabilator, which was then 
operated for 100 revolutions; after 100 revolutions the tablets 
were dusted and weighted. Friability was calculated by following 
formula.  
Friability (%) = (Initial weight–Final weight/Initial weight)×100. 
Water absorption ratio and wetting time  
A piece of tissue paper folded twice was placed in a small Petridish 
containing 6 ml of water. A tablet was placed on the paper and the 
time required for complete wetting was then measured by following 
formula. 
R = Wa-Wb/Wb×100; Where, Wa = weight of the tablet after absorption 
of water, Wb= weight of the tablet before an absorption of water.  
Disintegration studies  
In vitro disintegration time was performed by USP disintegration 
apparatus at 50 rpm. Phosphate buffer (pH 6.8), 600 ml was used as 
disintegration medium, the temperature was maintained at 37±2̊ C 
and one tablet was placed in each of the six basket tubes of the 
apparatus and one disc was added to each tube. The time taken for 
the complete disintegration of the tablet (at which, when no mass 
remaining in the apparatus) was noted.  
In vitro dissolution studies 
In vitro dissolution studies for all the fabricated tablets was carried 
out using USP paddle method at 50 rpm in 900 ml of phosphate 
buffer (pH 6.8) as dissolution media, maintained at 37±0.5 °C 
temperature. 5 ml aliquot was withdrawn at the specified time 
intervals, filtered through what man filter paper and assayed 
spectorphotometrically at 210 nm. An equal volume of fresh 
medium, which was pre warmed at 37 °C was replaced in the 
dissolution media after each sampling to maintain the constant 
volume throughout the test. 
Calibration curve of ramipril UV spectroscopy 
We have tried various concentrations ranges to find out the 
optimised concentration range, which obey Beer’s Lambert law and 
find out the optimized concentration in the range of 10-60 µg/ml. 
Apparatus  
A UV PROB 1700 ultraviolet-visible spectrometer, Shimadzu with 10 
mm matched quartz cell was used in the present investigation. 
Preparation of stock solution 
A stock solution of Ramipril was prepared by dissolution 100 mg 
accurate weight of standard Ramipril in 100 ml of methanol. Stock 
solution was suitable diluted to give concentration of 10 µg/ml and 
this was scanned in UV range the absorption maximum of Ramipril 
was observed at 210 nm the value was chosen for the preparation of 
the calibration curve of Ramipril.  
Working standard solution  
Working standard solution 100 µg/ml was made from the solution 
by suitable diluted with methanol. Aliquots was prepared by taken 1, 
2, 3, 4, 5 & 6 ml from working standard solution and diluted with 
methanol in 10 ml volumetric flask to give concentration 
10,20,30,40,50 & 60 µg/ml the absorption was recorded at 210 nm 
again a reagent blank and calibration curve was plotted and shown 
in fig. 3. 
 
 





Pre compression parameter 
Bulk density 
Both loose bulk density (LBD) and tapped bulk density (TBD) were 
determined. Bulk density, was found in the range of 0.64-0.85 g/cm3 
and the tapped density was found between 0.68-0.98 g/cm3
Hausner’s ratio  
. The 
results were tabulated and data shown in table 2.  
Hausner’s ratio was found in the range of 1.06-1.16 g/cm3
Percentage compressibility index 
. The 
results were tabulated and data shown in table 2.  
Percentage compressibility of powder mix was determined by the 
Carr’s Compressibility Index. The compressibility index was found 
between 10.94-13.27 which indicates a good flowbility of the 
powder blend. The outcomes were tabulated and data demonstrated 
in table 2. 
Angle of repose  
The frictional forces in loose powder or granules can be measured 
by the angle of repose. The good flow ability of the powder blend 
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was also demonstrated with the angle of repose in the range of 
(23.23-26.33) which is below 40 (θ˚) indicating good flow properties 
of the granules. The outcomes were tabulated and data 
demonstrated in table 2. 
 
Table 2: Pre compression parameter of different FDT formulation (F1-F5) 
Formulation code F1 F2 F3 F4 F5 
Bulk Density (g/cm³)* 0.85 0.78 0.69 0.64 0.66 
Tapped Density (g/cm³)* 0.98 0.88 0.75 0.68 0.77 
Hausner’s ratio* 1.15 1.12 1.08 1.06 1.16 
Carr’s Compressibility Index %* 11.93 12.64 10.94 13.27 12.76 
Angle of Repose (θ˚)* 25.33 24.43 26.33 23.23 25.64 
*n=3, Average of three determinations; F1-F5= formulation code of Fast dissolving tablet  
 
Post compression parameters 
Thickness uniformity 
The aim of the present study was to check the uniformity of 
thickness of the tablet. The outcomes were tabulated and data 
demonstrated in table 3.  
Hardness testing 
The hardness of the tablet was determined using a Monsanto 
hardness tester. The harshness of the prepared tablet varied from 
3.4±0.25 to 3.9±0.27 kg/cm2, which have satisfactory strength to 
resist the mechanical shocks.  
The hardness for all the formulations was within 3.5-4.0 kg/cm3, 
which is a suitable scope of oral disintegration tablets. The outcomes 
were tabulated and data demonstrated in table 3. 
Friability test 
Friability test is performed to assess the effect of friction and shocks; 
Roche Friabilator was used for the purpose. The friability was found 
between 0.42-0.52.  
The friability of all the formulation was found to be less than 1.0% 
indicating good mechanical strength to packaging operations and 
transportation. The outcomes were tabulated and data 
demonstrated in table 3. 
  
Table 3: Post compression parameter of different FDT formulation 
Formulation code F1 F2 F3 F4  F5 
Uniformity of weight (n=10) 245±1.18 248.91±2.06 249±1.34 250±1.79 251±1.78 
Thickness (mm) (n=3) 2.8±0.03 2.7±0.01 2.7±0.04 2.6±0.02 2.7±0.06 
Hardness (n=3) (kg/cm³) 3.4±0.25 3.9±0.27 3.5±0.26 3.7±0.25 3.8±0.24 
Friability (%) (n=10) 0.52 0.46 0.43 0.42 0.44 
Water absorption ratio (n=3) 62.00±0.89 64.00±0.24 65.00±0.91 68.00±0.8 67.00±0.32 
Wetting Time (s) (n=3) 37±1.09 35±1.07 33±1.23 29±0.30 35±1.94 
Disintegrating time 
(s) (n=3) 
32±0.220 31±0.200 31±0.220 29±0.320 29±0.620 
*n=3, Average of three determinations for thickness, hardness, Water absorption ratio, wetting time and disintegration time,; n=10, Average of ten 
determinations for weight uniformity and friability. s denoted time in second.  
 
Water absorption ratio and wetting time  
The Water absorption ratio founded between 62.00±0.89-
68.00±0.85; the water absorption ratio increased with an increase in 
the concentration of superdisintegrants. This increased behavior 
due to the water taking ability of superdisintegrants. The wetting 
time found between 29±0.30-37±1.09. The outcomes were tabulated 
and data demonstrated in table 3. It was found that the formulation 
F4 containing Sodium starch glycolate at concentration 65 mg and 
crospovidone at the concentration of 55 mg showed less wetting 
time i.e. 29±0.30s as compared to other formulations.  
Disintegration studies 
In vitro disintegration time was done by the USP dissolution 
apparatus. The disintegration rate has a correlation with water 
absorption capacity of disintegrate and The In vitro disintegration 
time was found between 29±0.320-32±0.220 s. The outcomes were 
tabulated and data demonstrated in table 3. All the formulation 
showed disintegration time less than 35 s. It was found that the 
formulation F4 will show least disintegration time 29s as compare to 
other formulation. The order for a disintegration time in fast 
dissolving tablet was found to be F4<F5<F2<F3<F1. 
In vitro Dissolution studies 
Dissolution rate depends on the wetting time of the disintegrant, 
among all the formulations F4 has less wetting time and has greater 
dissolution rate and then this is the other conformance test for 
correct selection of desirable. In vitro dissolution studies of all the 
formulation were done and depicted in fig. 4. In all formulations F4 
formulation was selected as the promising formulation. Containing 
Sodium starch glycolate, and Crospovidone as superdisintegrants it 
showed increased in vitro drug release. Fig. 4 represent the enhance 




Fig. 4: In-vitro dissolution study of different FDT formulation 
(F1, F2, F3, F4, F5) 
5 Batches of fast dissolving tablets were evaluated. F1-F5 were 
formulation code for fast dissolving tablet and F4 selected as 
promising formulation, that provide drug release about 92.5% in 12 
minute; USP paddle apparatus was used, 50 rpm and 900 ml of 
phosphate buffer (pH 6.8) as dissolution media, maintained at 
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37±0.5 °C temperature and assayed UV-spectorphotometrically at 
210 nm. 
DISCUSSION 
In this work, we have attempted to enhance the dissipation rate and 
decay rate of the fast dissolving tablet of Ramipril to provide quick 
onset of action for the patients of High blood pressure. The FDTs 
were prepared by direct compression method. The powder blend for 
all formulations containing various concentrations of Sodium starch 
glycolate (50-70 mg) and crospovidone (55 mg) as 
superdisintegrants was prepared and then the FTIR studies of 
Ramipril, crospovidone and combination of both were done that 
suggest compatibility (Fig.1). This study suggested that the drug and 
excipient are compatible to each other. The tablets were prepared 
by direct compression method using a single tablet punching 
machine. These tablets were evaluated for uniformity of weight, 
thickness, hardness, friability, the water absorption ratio, wetting 
time, disintegration time and In-vitro dissolution time. The order of 
uniformity of the thickness of tablet was found to be 
F4<F2<F3<F5<F1. It was observed that all the tablet passes the test 
for weight variation as shown in table. 3. Hardness of all tablets was 
between 3.4±0.25 to 3.9±0.27 kg/cm2
We are grateful to the Principal of SIPS, Sagar, for providing us the 
necessary facilities to stock out the research work. We are also 
thankful to Alkam pharmaceutical Ltd, Baddi, (India), 
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while friability was below 1% 
showed that all tablets have good mechanical strength. The order of 
hardness of the tablet was found to be F1<F3<F4<F5<F2. In 
comparing to all formulation tablets F4 batch containing sodium 
starch glycolate (65 mg), Crospovidone (55 mg), microcrystalline 
cellulose (90 mg), Lactose (15 mg), Talc (2.5 mg), Mg. Stearate (2.5 
mg) showed the highest water absorption ratio. Sodium starch 
glycolate with Crospovidone inhibited wicking action, increase 
porously provider pathway for the penetration of fluid into a tablet. 
The order of friability of the tablet was found to be 
F4<F3<F5<F2<F1. It was found that as the concentration of 
crospovidone (55 mg) and sodium starch glycolate (65 mg) fasten 
the dissolution rate and the disintegration rate. The dissolution 
studies of formulation batches show good dissolution behavior 
(Fig.4). The formulation containing sodium starch glycolate (65 mg) 
batch F4 showed 92.5% drug release within 12 min as compared to 
other formulation code F1, F2, F3, F5 that release 60-80% (Fig.4). 
Disintegration time of all tablets was observed within the fraction of 
time.  
CONCLUSION  
The use of superdisintegrants for preparation of a fast dissolving 
tablet is highly effective and commercially feasible. The use of 
superdisintegrants accelerates the disintegration of the tablet by 
virtue of their ability to absorb a large number of the water when 
exposed to an aqueous environment. FDTs may be developed for 
Ramipril, for quick onset of action without the need of water for 
swallowing or administration. It was clear that the dissolution and 
disintegration of Ramipril have improved considerably in batch F4 
formulation as compared to rest of the formulation. Batch F4 FDT 
showed good dissolution efficiency and rapid dissolution. This study 
was concluded that the dissolution rate of Ramipril can be enhanced 
to a great extent by the direct compression technique with the 
addition of superdisintegrants, however further studies are 
investigations are needed to confirm the in vivo efficiency. 
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